Literature DB >> 22999908

Acute hepatitis E during biotherapy.

Hélène Bauer1, Jean Sibilia, Paul Moreau, Laurent Messer.   

Abstract

Hepatitis E is a rare and usually asymptomatic infection. However, its incidence is rising in France, and it can cause severe or chronic manifestations in immunocompromised patients. Here, we report a case of hepatitis E in a patient with rheumatoid arthritis who had immunosuppression due to treatment with a biological agent.
Copyright © 2012 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22999908     DOI： 10.1016/j.jbspin.2012.08.001

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


  2 in total

1.  Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study.

Authors:  Hélène Bauer; Cécile Luxembourger; Jacques-Eric Gottenberg; Sophie Fournier; Florence Abravanel; Alain Cantagrel; Emmanuel Chatelus; Pascal Claudepierre; Christophe Hudry; Jacques Izopet; Sylvie Fabre; Guillaume Lefevre; Laurent Marguerie; Antoine Martin; Laurent Messer; Anna Molto; Béatrice Pallot-Prades; Yves-Marie Pers; Anne-Marie Roque-Afonso; Christian Roux; Christelle Sordet; Martin Soubrier; Claire Veissier; Daniel Wendling; Jean-Marie Péron; Jean Sibilia
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

2.  Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.

Authors:  Hidekazu Ikeuchi; Kana Koinuma; Masao Nakasatomi; Toru Sakairi; Yoriaki Kaneko; Akito Maeshima; Yuichi Yamazaki; Hiroaki Okamoto; Toshihide Mimura; Satoshi Mochida; Yoshihisa Nojima; Keiju Hiromura
Journal:  Case Rep Rheumatol       Date:  2018-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.